Teva Pharmaceutical Industries Ltd 8-K Filing
Ticker: TEVJF · Form: 8-K · Filed: Dec 11, 2025 · CIK: 818686
| Field | Detail |
|---|---|
| Company | Teva Pharmaceutical Industries Ltd (TEVJF) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2025 |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Teva Pharmaceutical Industries Ltd (ticker: TEVJF) to the SEC on Dec 11, 2025.
How long is this filing?
Teva Pharmaceutical Industries Ltd's 8-K filing is 3 pages with approximately 886 words. Estimated reading time is 4 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 886 words · 4 min read · ~3 pages · Grade level 15.2 · Accepted 2025-12-11 16:31:29
Filing Documents
- d46386d8k.htm (8-K) — 27KB
- d46386dex101.htm (EX-10.1) — 62KB
- 0001193125-25-316063.txt ( ) — 212KB
- teva-20251210.xsd (EX-101.SCH) — 3KB
- teva-20251210_lab.xml (EX-101.LAB) — 17KB
- teva-20251210_pre.xml (EX-101.PRE) — 11KB
- d46386d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TEVA PHARMACEUTICAL INDUSTRIES LIMITED Date: December 11, 2025 By: /s/ Eli Kalif Eli Kalif Executive Vice President, Chief Financial Officer 2